Perfect Medical Industry Co., Ltd. (6543) fair value: what the stock is really worth
As of Nov 6, 2026: fair value (intrinsic value) of Perfect Medical Industry Co., Ltd. stock TWD 9.38, price TWD 16.70, that is 43.8% below the price, quality 30 out of 100. Rating: strongly overvalued. Calculated from audited financials with 15 of our 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 4, 2026.
How to read this chart
60‑month range 12.11 TWD – 30.28 TWD · fair‑value band 8.76 TWD – 11.38 TWD · the 16.70 TWD price screens above the 9.38 TWD fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 4, 2026.
Follow Perfect Medical Industry Co. in your weekly email
Every Wednesday you see whether Perfect Medical Industry Co. is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Perfect Medical Industry Co., Ltd. manufactures and sells health and medical supplies in Taiwan and internationally.
Show moreShow less
It provides hemodialysis blood tubing sets, A.V. fistula needle sets, huber needle/winged needle sets, blood transfusion sets, safety infusion sets, safety extension sets, I.V. locks, and medical face masks, as well as disposable syringes.
The company also offers its products under the PF brand in Asia, Africa, Europe, and South America. Perfect Medical Industry Co., Ltd. was founded in 1989 and is headquartered in Changhua, Taiwan.
Stock analysis
Perfect Medical Industry Co., Ltd. (6543) currently trades at 16.70 TWD, while our model-based Fair Value estimate is 9.38 TWD, 44% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Multiples group reads highest at a median of 16.66 TWD per share, and 3 of the 15 models we run sit above the 16.70 TWD price.
Bear case: the Asset-Based group reads lowest at 2.17 TWD, and 12 of the 15 models stay below the price. Data coverage for this calculation is low.
Scenario range: 8.76 TWD (bear) to 11.38 TWD (bull), the price of 16.70 TWD sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 30/100 (below-average quality), in the Healthcare sector.
Weak Growth: Revenue growth is weak: less than 2 % a year.
Perfect Medical Industry Co., Ltd. reported revenue of 779M TWD in FY2025 versus 725M TWD in FY2021, a compound +1.8%/yr. Reported net income was 54.2M TWD in FY2025, compounding +8.8%/yr from FY2021.
Key figures
Market cap 1.1B TWD (≈ $32.2M) Micro · P/E ratio 28.8 · P/S ratio 1.19 · EPS (TTM) 0.5800 TWD · Dividend yield 1.2% · Net margin 4.0% · Return on equity 4.4% · Return on assets (EBIT) 4.8% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 30 out of 100 (low confidence).
What moves the price
The share trades about 43% below its 52-week high and 1% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −44% fair-value upside, at −44%, 6543 screens cheaper than that median.
Fair Value models
Bear8.76 TWDFair Value 9.38 TWDBull11.38 TWD
Price 16.70 TWD · Downside -43.8%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (0.3302 TWD per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
Residual Income10.50 TWD11.04 TWD12.00 TWD76
EPV7.05 TWD7.88 TWD8.60 TWD74
ROIC Compounder7.05 TWD7.88 TWD8.60 TWD72
All 15 models by family
Earnings-Based
Graham-Dodd5.81 TWD12.11 TWD15.31 TWD66
PEG = 1.01.79 TWD2.56 TWD3.33 TWD57
EPV7.05 TWD7.88 TWD8.60 TWD74
Dividend Discount
Gordon GGM6.62 TWD9.91 TWD13.39 TWD68
DDM Multi-Stage6.62 TWD9.44 TWD12.67 TWD67
Multiples
P/E Multiple14.09 TWD18.79 TWD23.48 TWD63
P/S Multiple10.89 TWD14.52 TWD18.14 TWD58
P/B Multiple37.13 TWD49.51 TWD61.89 TWD55
EV/EBIT9.05 TWD12.48 TWD15.92 TWD66
EV/EBITDA18.38 TWD24.92 TWD31.46 TWD67
EV/Revenue6.10 TWD9.25 TWD12.40 TWD53
Asset-Based
NCAV (Graham)1.43 TWD2.17 TWD2.72 TWD54
Economic Profit
Residual Income10.50 TWD11.04 TWD12.00 TWD76
ROIC Compounder7.05 TWD7.88 TWD8.60 TWD72
Growth Earnings
Growth-Adj P/E10.30 TWD14.71 TWD19.12 TWD67
The fair value above starts from this blend and is adjusted for dilution from new shares.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.17/100
Revenue growth is weak: less than 2 % a year.
Revenue growth 1 year
+4.7%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+4.8%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−0.7%
Start year 2020 (pandemic)
Revenue growth 6 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+2.4%
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years), in TWD ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in TWD: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+1.6%
Earnings growth per share plus dividend.
Earnings per share, growth per year+0.4%
Dividend (yield on the price)1.2%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.16% → 7%
Compare Perfect Medical Industry Co., Ltd. with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Instruments & Supplies · 181 stocks
Beats the industry median on 4/13 measures
Overall it trails its industry peers.
Valuation
Quality Score30 · Bottom 25%
Fair Value upside−43.8% · Below median
Profitability
Return on equity (12 months)4.4% · Below median
Return on assets4.0% · Below median
Net margin (12 months)4.0% · Below median
Operating margin (12 months)3.1% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY)30.1% · Top 25%
Dividend yield (12 months)1.2% · Below median
Balance sheet
Debt / equity0.16× · Above median
Valuation Multiplesvs Medical Instruments & Supplies median · lower = cheaper
P/E (12 months)28.8× · Pricier than median
P/B1.29× · Cheaper than median
P/S (12 months)1.19× · Cheapest 25%
EV/EBITDA8.2× · Cheaper than median
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 25
FUTURE (revenue growth)100· sector 40
PAST (return on equity)18· sector 30
HEALTH (low debt)92· sector 96
DIVIDEND (yield)23· sector 32
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Perfect Medical Industry Co., Ltd. Fair Value". https://www.fairvalue-calculator.com/stock/6543
Frequently asked questions
Is Perfect Medical Industry Co., Ltd. (6543) overvalued or undervalued?
As of Nov 4, 2026, our model estimates a fair value of 9.38 TWD versus a price of 16.70 TWD, about 44% lower (overvalued).
What is the fair value of 6543?
Our model-based fair value for Perfect Medical Industry Co., Ltd. is 9.38 TWD (as of Nov 4, 2026), built from audited fundamentals. The current price: 16.70 TWD.
What is the quality score of 6543?
Perfect Medical Industry Co., Ltd. has a Quality Score of 30/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Perfect Medical Industry Co., Ltd. (6543)?
Our model-based price target is the fair value of 9.38 TWD (as of Nov 4, 2026) from 15 valuation models. Cautious scenario 8.76 TWD, optimistic scenario 11.38 TWD. It is a calculation from audited fundamentals, not an analyst target.
What is the Perfect Medical Industry Co., Ltd. stock forecast for 2026?
Our models put fair value at 9.38 TWD, about 44% lower versus a price of 16.70 TWD (overvalued). Cautious scenario 8.76 TWD, optimistic scenario 11.38 TWD. The calculation is refreshed regularly with new filings.
What is the revenue of Perfect Medical Industry Co., Ltd. (6543)?
Perfect Medical Industry Co., Ltd. reported trailing-twelve-month revenue of about 886M TWD (latest available figure, as of Nov 4, 2026).
Does Perfect Medical Industry Co., Ltd. pay a dividend?
Perfect Medical Industry Co., Ltd. currently shows a dividend yield of 1.17% relative to its recent price (as of Nov 4, 2026).
How much is the dividend of Perfect Medical Industry Co., Ltd. (6543) and when is the ex-dividend date?
Perfect Medical Industry Co., Ltd. pays a dividend of 0.195 TWD per share a year, a dividend yield of 1.2%. The last ex-dividend date was Sep 2, 2026. A dividend has been paid every year since at least 2019. The payout ratio is 33.6% of earnings. Our assessment: Watch coverage. The dividend isn’t fully covered by free cash flow or earnings, part of it is funded from reserves or debt. Fine for now, but worth watching: if it stays uncovered, the dividend could be cut.
What is the intrinsic value of Perfect Medical Industry Co., Ltd. (6543)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Perfect Medical Industry Co., Ltd. it is 9.38 TWD per share (as of Nov 4, 2026), against a price of 16.70 TWD. It is the blended result of 15 valuation models in 6 families (Earnings-Based, Dividend Discount, Multiples, Asset-Based, Economic Profit, Growth Earnings).
Is Perfect Medical Industry Co., Ltd. stock overvalued or undervalued in 2026?
As of Nov 4, 2026, 6543 trades above its calculated fair value: price 16.70 TWD, fair value 9.38 TWD, a gap of about −44% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 6543?
No. The price is what the market pays today (16.70 TWD); the fair value is what the company's own numbers justify (9.38 TWD). For Perfect Medical Industry Co., Ltd. the two are 7.32 TWD per share apart. That gap is exactly why we show both numbers side by side.
How much is Perfect Medical Industry Co., Ltd. worth?
The market values Perfect Medical Industry Co., Ltd. at about 1.1B TWD (market capitalisation, as of Nov 4, 2026). Per share that is 16.70 TWD; our models calculate a fair value of 9.38 TWD per share.
What do the bullish and bearish scenarios say about 6543?
Our models span a range for Perfect Medical Industry Co., Ltd.: cautious scenario 8.76 TWD, base 9.38 TWD, optimistic 11.38 TWD per share (as of Nov 4, 2026, price 16.70 TWD). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 6543?
Perfect Medical Industry Co., Ltd. trades at a price-to-earnings ratio of 28.8 (as of Nov 4, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 9.38 TWD is built from several models across several years. Other multiples: P/B 1.3, P/S 1.2, EV/EBITDA 8.2.
How solid is the balance sheet of Perfect Medical Industry Co., Ltd. (6543)?
Balance-sheet figures for Perfect Medical Industry Co., Ltd. (as of Nov 4, 2026): return on equity 4.4%, debt of 0.16 per unit of equity. They feed the Quality Score of 30/100, which measures business quality independently of the share price.
How far is 6543 from its 52-week high?
Perfect Medical Industry Co., Ltd. trades at 16.70 TWD, about 43% below its 52-week high of 29.29 TWD and 1% above the low of 16.50 TWD (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of 9.38 TWD is for.
Which stocks are comparable to Perfect Medical Industry Co., Ltd.?
From the same area (Healthcare) we also value Intuitive Surgical, Inc, EssilorLuxottica Société anonyme, Becton, Dickinson and Company, Medline Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Perfect Medical Industry Co., Ltd. stock attractive at the current price?
The data as of Nov 4, 2026: price 16.70 TWD, calculated fair value 9.38 TWD (−44%), Quality Score 30/100, from 15 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 6543 calculated?
We run Perfect Medical Industry Co., Ltd. through 15 models from 6 families: Earnings-Based, Dividend Discount, Multiples, Asset-Based, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of 9.38 TWD builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Perfect Medical Industry Co., Ltd. itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Perfect Medical Industry Co., Ltd. (6543)?
The closing price on Nov 6, 2026 was 16.70 TWD. Our model-based fair value is 9.38 TWD, about 44% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Perfect Medical Industry Co., Ltd. right now?
The price sits above even our optimistic bull case (11.38 TWD). The favourable scenario is already priced in. Weak quality (30/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
Key figures of Perfect Medical Industry Co., Ltd.
How large is the market capitalisation of Perfect Medical Industry Co., Ltd. (6543)?
The market capitalisation of Perfect Medical Industry Co., Ltd. is 1.1B TWD (≈ $32.2M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Perfect Medical Industry Co., Ltd. (6543)?
The price-to-sales ratio of Perfect Medical Industry Co., Ltd. is 1.19 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Perfect Medical Industry Co., Ltd. (6543)?
Earnings per share at Perfect Medical Industry Co., Ltd. are 0.5800 TWD (price ÷ EPS = P/E 28.8). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Perfect Medical Industry Co., Ltd. (6543)?
The dividend yield of Perfect Medical Industry Co., Ltd. is 1.2% (payout 33.6%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Perfect Medical Industry Co., Ltd. (6543)?
The net margin of Perfect Medical Industry Co., Ltd. is 4.0% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Perfect Medical Industry Co., Ltd. (6543)?
The return on equity (ROE) of Perfect Medical Industry Co., Ltd. is 4.4% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Perfect Medical Industry Co., Ltd. (6543)?
On an EBIT basis the return on assets of Perfect Medical Industry Co., Ltd. is 4.8% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Perfect Medical Industry Co., Ltd. (6543)?
The operating margin of Perfect Medical Industry Co., Ltd. is 3.1% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Perfect Medical Industry Co., Ltd. (6543)?
Revenue at Perfect Medical Industry Co., Ltd. is growing +30.1% versus a year earlier (3y avg +4.8%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Perfect Medical Industry Co., Ltd. (6543)?
Earnings per share at Perfect Medical Industry Co., Ltd. are growing −68.6% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Perfect Medical Industry Co., Ltd. (6543) generate?
The free cash flow of Perfect Medical Industry Co., Ltd. is −91.3M TWD (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Perfect Medical Industry Co., Ltd. (6543) carry?
The net debt of Perfect Medical Industry Co., Ltd. is 79.5M TWD (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Perfect Medical Industry Co., Ltd. in the live analysis
One click puts Perfect Medical Industry Co., Ltd. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Thin data
Nov 4, 2026